MD Becker Partners' 3rd Annual Cancer Immunotherapy: A Long-Awaited Reality conference taking place from 8:00 a.m. to 6:30 p.m. EDT on October 4, 2012, at the New York Academy of Medicine in New York...T), the first FDA-approved autologous cellular immunotherapy for cancer.
FULL ARTICLE AT The Motley Fool